SAMHD1 and neoplasm: Another potential strategy involves the development of small molecule inhibitors of SAMHD1, although these inhibitors face difficulties in selectively targeting SAMHD1 in tumor cells while sparing normal cells, which remain critical for immune function and viral defense.